Thus, age-related alterations in hepatic gene expression and ectopic lipid accumulation associated with insulin resistance and T2DM are substantially reversed through skeletal-muscle-specific activation of Akt1 and the corresponding increase in muscle mass. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.